Michał Taszner

Years Active: 2021-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Aleksandra Urban, Alan Majeranowski, Grzegorz Stasilojc, Patrycja Koszałka, Anna Felberg, Michał Taszner, Jan M Zaucha, Marcin Okrój
In Silico Designed Gain-of-Function Variants of Complement C2 Support Cytocidal Activity of Anticancer Monoclonal Antibodies. Cancers 14 (5) (2022)
Matteo Giaccherini, Angelica Macauda, Enrico Orciuolo, Marcin Rymko, Karolina Gruenpeter, Charles Dumontet, Malgorzata Raźny, Victor Moreno, Gabriele Buda, Katia Beider, Judit Varkonyi, Hervé Avet-Loiseau, Joaquin Martinez Lopez, Herlander Marques, Marzena Watek, María Eugenia Sarasquete, Vibeke Andersen, Lionel Karlin, Anna Suska, Marcin Kruszewski, Niels Abildgaard, Marek Dudziński, Aleksandra Butrym, Arnold Nagler, Annette Juul Vangsted, Katalin Kadar, Waldemar Tomczak, Krzysztof Jamroziak, Svend Erik Hove Jacobsen, Lene Hyldahl Ebbesen, Michał Taszner, Grzegorz Mazur, Fabienne Lesueur, Matteo Pelosini, Miriam Santero, Artur Jurczyszyn, Delphine Demangel, Rui Manuel Reis, Elżbieta Iskierka-Jażdżewska, Miroslaw Markiewicz, Federica Gemignani, Edyta Subocz, Daria Zawirska, Agnieszka Druzd-Sitek, Anna Stępień, M Henar Alonso, Juan Sainz, Frederico Canzian, Daniele Campa
Genetically determined telomere length and multiple myeloma risk and outcome. Blood cancer journal 11 (4) (2021)

Michał Taszner.css-eqlu8i{font-size:small;padding-left:4px;}